• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Novartis

Novartis

Page 4 of 4

Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Shares of Next-Gen Cancer Biotech Juno Rallied Today

By Contributing Writer
July 14, 2016
Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself
Health

Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself

By Crypto Correspondent
June 28, 2016
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
Health

This Is the Most Important Business Trend in Pharma

By Research Team
June 21, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health

These Are the Most Promising Experimental Cancer Drugs

By Contributing Writer
June 9, 2016
The Sad and Inspiring Reason This Top Novartis Exec Stepped Down
MPW

The Sad and Inspiring Reason This Top Novartis Exec Stepped Down

By Editorial Team
May 31, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health

Struggling Novartis Heart Drug Boosted by New Medical Guidelines

By News Correspondent
May 21, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health

Novartis Takes Entresto Case to U.S. Cardiologist Meeting

By Research Team
April 2, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health

Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law

By Investment Desk
March 31, 2016
Venezuela Tense As Unrest Over President Maduro's Government Continues
International

Venezuela Is Using Distressed Bonds to Pay Off Its Debts to Drugmakers

By Market Analyst
March 7, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Finance

Novartis Agrees to $390 Million Settlement

By Industry Analyst
November 20, 2015
Parkinson’s patients show improvement after taking cancer drug
Health

Parkinson’s patients show improvement after taking cancer drug

By Crypto Correspondent
October 19, 2015
France's Gevrise Emane (L) celebrates he
Leadership

40 Under 40: Advice I’d give my 20-year-old self

By Market Analyst
September 25, 2015
40 Under 40: The lowest moment in my career
Leadership

40 Under 40: The lowest moment in my career

By Digital Assets Editor
September 25, 2015
Novartis’s pathway to business longevity
Features

Novartis’s pathway to business longevity

By News Correspondent
March 21, 2013

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Tech Reporter
  • Economy
    The analyst who once predicted the 'end of capitalism' sees Zohran Mamdani as a 'day of reckoning coming in'—and...
    By News Correspondent
  • Big Tech
    Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
    By Digital Assets Editor
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.